Evicenter
MarkdownMedical informationP&T meetings
Darovasertib (IDE196)

First-line metastatic uveal melanoma, in combination with crizotinib

Also known as LXS196
Manufacturer
IDEAYA Biosciences
Launch
Not announced
Last updated
206 sources

Product information and disease descriptionProduct descriptionProduct information

Co-prescribed/Concomitant therapies

3 evidence topics · 3 sources

Antidiarrheal prophylaxis with the darovasertib and crizotinib combination

No evidence found.